<!DOCTYPE html>
<html lang="en">
  <head>
            
   

<meta charset="UTF-8" />
<meta name="viewport" content="width=device-width, initial-scale=1.0" />
<meta http-equiv="X-UA-Compatible" content="ie=edge" />

<link rel="shortcut icon" href="/wiki/assets/favicon.ico" type="image/x-icon" />

<title>AKI in Transplant Patients • Kang Rui Xiang's Notes</title>

<meta name="description" content="This is my wiki page" />

<meta property="og:title" content="AKI in Transplant Patients • Kang Rui Xiang's Notes" />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://kangruixiang.github.io/wiki//notes/AKI in transplant patients/" />
<meta property="og:image" content="/assets/avatar.png" />
<meta property="og:description" content="This is my wiki page" />

<link rel="canonical" href="https://kangruixiang.github.io/wiki//notes/AKI in transplant patients/" />

<link rel="stylesheet" href="/wiki/style.css" />

<style>
  @font-face {
    font-family: "Concourse";
    src: url("/wiki/assets/fonts/concourse_3_regular.woff2") format("woff2");
    font-style: normal;
  }
  @font-face {
    font-family: "Equity";
    src: url("/wiki/assets/fonts/equity_a_regular.woff2") format("woff2");
    font-style: normal;
  }
</style>

  </head>
  <body class="h-screen bg-ember scroll-smooth">
    <div
      class="fixed top-0 w-screen"
    >
    <div class="flex items-center justify-between max-w-4xl px-4 py-4 mx-auto md:px-10 bg-ember bg-opacity-90">
     <a href="/wiki/"> <svg xmlns="http://www.w3.org/2000/svg" class="w-8 h-8" viewBox="0 0 20 20" fill="currentColor">
  <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z" />
</svg></a>

      <nav class="flex space-x-2 font-semibold uppercase">
        <a href="/wiki/" class="p-4 rounded hover:bg-zinc-800 hover:text-zinc-200"
          >Home</a
        >
        <a
          href="/wiki/notes/Step 1"
          class="p-4 font-semibold rounded hover:bg-zinc-800 hover:text-zinc-200"
          >Step 1</a
          >
      </nav>
    </div>
    </div>

    <div class="flex items-center justify-center flex-none max-w-4xl px-6 mx-auto mt-32 mb-32">
      <div  class="font-serif prose prose-lg prose-h1:text-xl prose-h2:text-lg md:prose-2xl md:prose-h1:text-4xl md:prose-h2:text-3xl prose-hr:border-zinc-900 hover:prose-a:bg-zinc-800 hover:prose-a:text-zinc-200"><h1 id="aki-in-transplant-patients" tabindex="-1">AKI in transplant patients</h1>
<ul>
<li>related: <a href="/wiki/notes/Nephrology/">Nephrology</a></li>
<li>tags: #nephrology</li>
</ul>
<hr>
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/20220805110910.png" alt=""></p>
<p>This patient has acute kidney injury and electrolyte abnormalities while on tacrolimus and fluconazole; this should raise suspicion for <strong>calcineurin inhibitor nephrotoxicity</strong>.  Calcineurin inhibitors (eg, <strong>tacrolimus</strong>, <strong>cyclosporine</strong>) are common immunosuppressants used in organ transplantation; toxicity may be due to medication-induced <mark>vasoconstriction leading to renal ischemia</mark>.</p>
<p>Patients can have <strong>declining glomerular filtration rates</strong> and a variety of metabolic abnormalities, including <strong>hyperkalemia</strong>, hyperuricemia, <strong>hypophosphatemia</strong>, <strong>hypomagnesemia</strong>, hypercalciuria, and possibly metabolic acidosis.  Significant hypertension may also be present.  Toxicity is <mark>dose-dependent</mark>.  Calcineurin inhibitors are metabolized by <mark>cytochrome P450</mark> 3A4; levels are increased by other drugs that are metabolized by this enzyme (eg, <strong>azole antifungals,</strong> macrolides, non-dihydropyridine calcium channel blockers).</p>
<p><strong>Biopsy</strong> is often required to rule out acute rejection; histologic findings are nonspecific, but calcineurin inhibitor nephrotoxicity is suggested by the absence of signs of acute rejection (eg, interstitial inflammation, intimal arteritis, tubulitis).  Acute calcineurin inhibitor toxicity is usually reversible with drug cessation, although some patients develop residual chronic renal dysfunction.</p>
<p>Acute graft rejection most commonly occurs within the first 6 months post-transplant, unless the patient is noncompliant with immunosuppression.  In addition, significant proteinuria (&gt;1 g) is often present.</p>

      </div>
    </div>
    
     <div class="fixed hidden ml-8 right-[5%] 2xl:block top-48 border-l-2 border-zinc-600 px-2"> 
        
      </div>


    <div class="max-w-4xl p-2 mx-auto font-sans font-semibold uppercase bg-emberdark">Backlinks</div>
    <div class="mx-auto font-serif prose prose-lg hover:prose-a:bg-zinc-800 hover:prose-a:text-zinc-200">
      
      <!-- <hr /> -->



<ul>
  
  <li>
    <div class="">
      <a href="/wiki//notes/Nephrology/" class="peer">Nephrology</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="nephrology" tabindex="-1">Nephrology</h1>
<hr>
<ul>
<li>Keywords:: <a href="/wiki/notes/Step%203/">Step 3</a>, <a href="/wiki/notes/Medicine/">Medicine</a></li>
</ul>
<hr>
<h2 id="to-learns" tabindex="-1">To learns</h2>
<ul>
<li>ANCA vasculitis</li>
<li>[ ] stones: citrate and calcium physiology</li>
</ul>
<h2 id="mksap" tabindex="-1">MKSAP</h2>
<p>Chapter 01Clinical Evaluation of Kidney Function
Chapter 02Fluids and Electrolytes
Chapter 03Acid-Base Disorders
Chapter 04Hypertension
Chapter 05Chronic Tubulointerstitial Nephritis
Chapter 06Glomerular Diseases</p>
<ul>
<li><a href="/wiki/notes/Kidney%20Manifestations%20of%20Deposition%20Diseases/">Kidney Manifestations of Deposition Diseases</a>
Chapter 08Genetic Disorders and Kidney Disease
Chapter 09Acut</li>
</ul>

      </div>
    </div>
  </li>
  
</ul>


</div>

    <footer>
      <div class="max-w-6xl mx-auto mb-10 text-sm text-center mt-96">
        By Kang Rui Xiang
      </div>
      </div>
    </footer>
  </body>
</html>
